These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 13827793)

  • 41. Frequency of BCR-ABL fusion transcripts in Serbian patients with chronic myeloid leukemia.
    Todoric-Zivanovic B; Strnad M; Stamatovic D; Tukic L; Krtolica K; Tatomirovic Z; Djordjevic V; Bogdanovic A; Jankovic G; Magic Z
    J BUON; 2011; 16(1):104-7. PubMed ID: 21674858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia.
    Hariharan IK; Adams JM; Cory S
    Oncogene Res; 1988; 3(4):387-99. PubMed ID: 3147434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides.
    Skórski T; Szczylik C; Malaguarnera L; Calabretta B
    Folia Histochem Cytobiol; 1991; 29(3):85-9. PubMed ID: 1794439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation.
    Rahmani M; Nguyen TK; Dent P; Grant S
    Mol Pharmacol; 2007 Sep; 72(3):788-95. PubMed ID: 17595328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.
    Dhingra K; Talpaz M; Kantarjian H; Ku S; Rothberg J; Gutterman JU; Kurzrock R
    Leukemia; 1991 Mar; 5(3):191-5. PubMed ID: 2013978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic myeloid leukaemia. I. Some observations on chronic myeloid leukaemia.
    GALTON DA
    Br J Radiol; 1953 Jun; 26(306):285-90. PubMed ID: 13051542
    [No Abstract]   [Full Text] [Related]  

  • 47. [The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine].
    Sun JR; Zhang XH; He ZW; Gu Y; Yu YZ; Fang YM; Lü QH; Dong QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2246-51. PubMed ID: 17064567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Detection of BCR-ABL in Chronic Myeloid Leukemia.
    Qin YZ; Huang XJ
    Methods Mol Biol; 2016; 1465():1-15. PubMed ID: 27581134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leucocyte agglutinin resulting from transfusions in a case of chronic myelogenous leukemia.
    KILLMANN SA
    Dan Med Bull; 1956 Nov; 3(7):211-3. PubMed ID: 13384049
    [No Abstract]   [Full Text] [Related]  

  • 50. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic Myeloid Leukemia (CML) Mouse Model in Translational Research.
    Peng C; Li S
    Methods Mol Biol; 2016; 1438():225-43. PubMed ID: 27150093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic myelogenous leukemia.
    BOONE DW
    J Osteopath (Kirksvill); 1953 Jan; 60(1):21-3. PubMed ID: 13023499
    [No Abstract]   [Full Text] [Related]  

  • 53. Thromboelastographic studies of blood coagulation in atherosclerosis.
    GONCIARZ Z
    Acta Med Pol; 1961; 2():247-57. PubMed ID: 13900138
    [No Abstract]   [Full Text] [Related]  

  • 54. [Thromboelastographic study of the action of dextran on processes of blood coagulation].
    ESPOSITO S; CAPPELLETTI GA
    Arch Sci Med (Torino); 1959 Aug; 108():127-37. PubMed ID: 13820821
    [No Abstract]   [Full Text] [Related]  

  • 55. [THROMBOELASTOGRAPHIC STUDIES ON BLOOD COAGULATION IN SCHIZOPHRENIA].
    ALEKSANDROWICZ J; DZIKOWSKI H; SCHIFFER Z
    Neurol Neurochir Psychiatr Pol; 1964; 14():283-8. PubMed ID: 14214621
    [No Abstract]   [Full Text] [Related]  

  • 56. [Preliminary studies on the 24-hour rhythm of blood coagulation in normal subjects. (A thromboelastographic method)].
    LISIEWICZ J; SCHIFFER Z
    Acta Physiol Pol; 1962; 13():277-84. PubMed ID: 14465793
    [No Abstract]   [Full Text] [Related]  

  • 57. [Thromboelastographic investigations of the coagulation of lymph].
    ALBERINI B; LODI R; NAVA C
    Boll Soc Ital Biol Sper; 1961 Sep; 37():890-2. PubMed ID: 13860078
    [No Abstract]   [Full Text] [Related]  

  • 58. [Thromboelastographic study of the action of 6-aminonicotinamide on blood coagulation processes].
    ESPOSITO S; SOARDI F
    Arch Sci Med (Torino); 1959 Dec; 108():865-70. PubMed ID: 13820827
    [No Abstract]   [Full Text] [Related]  

  • 59. [EXPERIENCES WITH THROMBOELASTOGRAPHIC TEST OF BLOOD COAGULATION IN PSYCHOSES. II].
    SZYMBORSKI B; PUZYNSKI S; SKRZYDLEWSKI Z
    Psychiatr Neurol (Basel); 1965; 149():160-3. PubMed ID: 14322678
    [No Abstract]   [Full Text] [Related]  

  • 60. [Note on the reproducibility of the thromboelastographic method].
    PARREIRA F; NUNES V
    Hemostase; 1961; 1():69-74. PubMed ID: 14484047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.